GAMMA Investing LLC Has $287,000 Stock Position in Revvity Inc. (NYSE:RVTY)

GAMMA Investing LLC grew its holdings in shares of Revvity Inc. (NYSE:RVTY) by 42.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,713 shares of the company’s stock after purchasing an additional 815 shares during the quarter. GAMMA Investing LLC’s holdings in Revvity were worth $287,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of the business. Nissay Asset Management Corp Japan ADV boosted its holdings in Revvity by 0.6% in the fourth quarter. Nissay Asset Management Corp Japan ADV now owns 15,023 shares of the company’s stock worth $1,682,000 after purchasing an additional 91 shares in the last quarter. Quarry LP lifted its position in shares of Revvity by 45.7% in the fourth quarter. Quarry LP now owns 303 shares of the company’s stock worth $34,000 after buying an additional 95 shares during the last quarter. Signaturefd LLC boosted its stake in shares of Revvity by 6.8% during the 4th quarter. Signaturefd LLC now owns 1,668 shares of the company’s stock worth $186,000 after acquiring an additional 106 shares in the last quarter. RDA Financial Network increased its holdings in shares of Revvity by 3.6% during the 1st quarter. RDA Financial Network now owns 3,331 shares of the company’s stock valued at $352,000 after acquiring an additional 115 shares during the last quarter. Finally, EverSource Wealth Advisors LLC raised its stake in shares of Revvity by 33.5% in the 4th quarter. EverSource Wealth Advisors LLC now owns 522 shares of the company’s stock valued at $58,000 after acquiring an additional 131 shares in the last quarter. Institutional investors and hedge funds own 86.65% of the company’s stock.

Wall Street Analysts Forecast Growth

RVTY has been the subject of several analyst reports. UBS Group upgraded Revvity from a “neutral” rating to a “buy” rating and reduced their target price for the stock from $145.00 to $115.00 in a report on Thursday, May 1st. Barclays reduced their price objective on shares of Revvity from $140.00 to $110.00 and set an “overweight” rating for the company in a research note on Thursday, April 10th. Raymond James Financial reaffirmed an “outperform” rating and set a $120.00 price objective (down from $145.00) on shares of Revvity in a report on Tuesday, April 29th. Bank of America dropped their target price on shares of Revvity from $116.00 to $110.00 and set a “buy” rating on the stock in a report on Thursday, June 26th. Finally, Robert W. Baird cut their target price on shares of Revvity from $127.00 to $125.00 and set an “outperform” rating for the company in a research report on Tuesday, April 29th. Four analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Revvity has a consensus rating of “Moderate Buy” and a consensus target price of $123.64.

Revvity Stock Performance

NYSE RVTY opened at $100.90 on Thursday. The company’s fifty day moving average is $93.78 and its two-hundred day moving average is $105.09. Revvity Inc. has a 52-week low of $87.70 and a 52-week high of $129.50. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.58 and a quick ratio of 2.99. The firm has a market capitalization of $11.89 billion, a price-to-earnings ratio of 42.94, a P/E/G ratio of 2.50 and a beta of 0.98.

Revvity (NYSE:RVTY) last released its earnings results on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.05. Revvity had a net margin of 10.35% and a return on equity of 7.73%. The business had revenue of $664.76 million during the quarter, compared to analysts’ expectations of $662.30 million. During the same quarter last year, the company earned $0.98 earnings per share. The firm’s revenue was up 2.3% on a year-over-year basis. Equities research analysts forecast that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Shareholders of record on Friday, July 18th will be given a $0.07 dividend. The ex-dividend date is Friday, July 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.28%. Revvity’s dividend payout ratio is currently 11.91%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.